Shanghai Pharma Sells Remaining Shares In Shanghai New Hualian Pharma
This article was originally published in PharmAsia News
Executive Summary
After the earlier transfer of 90.31% of its shares to Shanghai New Hualian Pharmaceutical Co., Ltd., Shanghai Pharmaceuticals Holding Co., Ltd. has listed its remaining 9.69% holding in the company at RMB 40.6576 million, up 277.56% since its prior listing.